Sascha Tillmanns
Technik-/Wissenschafts-/F&E-Leiter bei SuppreMol GmbH
Ursprung des Netzwerks ersten Grades von Sascha Tillmanns
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
SuppreMol GmbH
SuppreMol GmbH Pharmaceuticals: MajorHealth Technology SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sascha Tillmanns
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
The Caisse de dépôt et placement du Québec
The Caisse de dépôt et placement du Québec Investment ManagersFinance The Caisse de dépôt et placement du Québec (CDPQ) is a government-owned institutional fund manager headquartered in Montréal, Canada. Founded in 1965, CDPQ manages the funds of several depositor groups primarily for public and parapublic pension and insurance plans which pay out benefits to more than two million Quebecers each year. | Investment Managers | Director/Board Member | |
IBEX TECHNOLOGIES | Medical Specialties | Director/Board Member | |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Pharmaceuticals: Major | President | |
VECTURA GROUP | Pharmaceuticals: Major | Director/Board Member | |
4SC AG | Biotechnology | Chairman | |
PARI Pharma GmbH
PARI Pharma GmbH Pharmaceuticals: MajorHealth Technology PARI Pharma GmbH Manufactures inhalant drugs. It offers aerosol inhalats and nebulizers which are primarily used against respiratory conditions. The company was founded in 1997 and is headquartered in Starnberg, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AFFIMED N.V. | Biotechnology | Chairman | |
EVOTEC SE | Pharmaceuticals: Major | Corporate Officer/Principal | |
MEDIGENE AG | Biotechnology | Director/Board Member | |
BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Patheon UK Ltd.
Patheon UK Ltd. Pharmaceuticals: OtherHealth Technology Patheon UK Ltd. provides pharmaceutical drug development and manufacturing services. It provides its services to the pharmaceutical and biotechnology industries. The company is headquartered in Abingdon, UK | Pharmaceuticals: Other | Corporate Officer/Principal | |
RIEMSER Pharma GmbH
RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany. | Pharmaceuticals: Major | Director/Board Member | |
McGill University | College/University | Graduate Degree | |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Investment Committee Member | |
BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member | |
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland. | Miscellaneous Commercial Services | Chairman | |
University of Gottingen | College/University | Doctorate Degree | |
Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Doctorate Degree | |
Fertin Pharma A/S
Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Fertin Pharma A/S develops and manufactures medical chewing gum. It offers pharmaceutical and nutraceutical chewing gum products. The company was founded in 1915 and is headquartered in Vejle, Denmark. | Food: Specialty/Candy | Chairman | |
American Chamber of Commerce in Germany eV
American Chamber of Commerce in Germany eV Miscellaneous Commercial ServicesCommercial Services American Chamber of Commerce in Germany eV engages in the enhancement of global economic and trade relations. The company was founded on January 29, 1903 and is headquartered in Frankfurt am Main, Germany. | Miscellaneous Commercial Services | Director/Board Member | |
PharmaSwiss SA
PharmaSwiss SA Medical DistributorsDistribution Services PharmaSwiss SA engages in the provision of healthcare solutions. It also offers consulting services. The company was founded on January 24, 2000 and is headquartered in Zug, Switzerland. | Medical Distributors | Chairman | |
Sir George Williams University | College/University | Undergraduate Degree | |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Lophius Biosciences GmbH
Lophius Biosciences GmbH Medical/Nursing ServicesHealth Services Lophius Biosciences GmbH develops and markets T-cell-based diagnostic test systems. The firm specializes in the development of products for the diagnosis and immuno monitoring of virus-specific immune responses. It also provides customized services in the field of cell-based bioactivity, as well as quality tests for pharmaceutical active substances. The firm focuses on improving therapy control and personalized treatment of patients in the area of transplantation medicine and infectious and autoimmune diseases. The company was founded by Ludwig Deml and Fritz Schwarzmann in 2002 and it is headquartered in Regensburg, Germany. | Medical/Nursing Services | Chief Executive Officer | |
CM&D Pharma Ltd.
CM&D Pharma Ltd. Pharmaceuticals: MajorHealth Technology CM&D Pharma Ltd. provides pharmaceutical products. It is a specialty pharmacy company focused on foods for special medical purposes. Its products include Fostrap CKD, Recoclix, SilSOS, Eviendep, and Ossulin. The company was founded in 2007 and is headquartered in Surrey, UK. | Pharmaceuticals: Major | Chairman | |
Cell Medica Switzerland AG
Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Pharmaceuticals: Major | Founder | |
GlaxoSmithKline GmbH & Co. KG
GlaxoSmithKline GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline GmbH & Co. KG is a German pharmaceutical company. The company is based in Munich, Germany. The CEOs of the company are Jean-Bernard Siméon, Adrian Bauer. | Pharmaceuticals: Major | Chief Executive Officer | |
Central Europe GmbH | Corporate Officer/Principal | ||
Pharmathen SA
Pharmathen SA Pharmaceuticals: MajorHealth Technology Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece. | Pharmaceuticals: Major | Chairman | |
Amgen (Europe) GmbH | Sales & Marketing | ||
Shire Deutschland GmbH
Shire Deutschland GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland GmbH develops therapies for patients with rare and other specific diseases. The company is based in Berlin, Germany. The CEOs are Uwe Fröhlich, Heidrun Irschik-Hadjieff, Karsten Meisloch. The German company was founded in 1986. | Pharmaceuticals: Major | Chief Executive Officer | |
Paul Ehrlich-Foundation | Director/Board Member | ||
Robert Koch Stiftung eV | Director/Board Member | ||
Lipideon Biotechnology AG
Lipideon Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Lipideon Biotechnology AG engages in the provision of pharmaceutical activities. The company was founded on February 26, 2002 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Chairman | |
Convatec (Germany) GmbH
Convatec (Germany) GmbH Medical DistributorsDistribution Services Part of Convatec Group Plc, Convatec (Germany) GmbH wholesales pharmaceutical products. The company is based in Munich, Germany. The CEOs of the German company are Clare Jane Bates, Mercedes Armendariz, Tanja Dormels. | Medical Distributors | Corporate Officer/Principal | |
Humabs BioMed SA
Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
HHC consulting | Founder | ||
Affimed AG | Chairman | ||
Claudio BidCo A/S
Claudio BidCo A/S Financial ConglomeratesFinance Claudio BidCo A/S operates as an investment company with interests in development and manufacturing of medicated chewing gum. The company was founded on November 24, 2016 and is headquartered in Vejle, Denmark. | Financial Conglomerates | Chairman | |
Robert Koch Foundation | Director/Board Member | ||
CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member | |
BSN medical GmbH
BSN medical GmbH Pharmaceuticals: MajorHealth Technology BSN medical GmbH develops and markets wound care and related vascular diseases, lymphology and non-invasive orthopedic products. The firm specializes in the supply and manufacture of medical accessories for wound care, compression therapy, orthopedics, fracture management, physiotherapy and bandage applications. It markets products under brands, such as Leukoplast, Leukomed, Gypsona, Orthoglass, JOBSt, Radiante, Delta-cast, Actimove and Tridocur. Its focus areas encompass product innovation, brand development and hands-on training and workshops. The company was founded in April 2001 and is headquartered in Hamburg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Bristol-Myers Squibb GmbH & Co. KGaA
Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
Deutschland | 25 |
Schweiz | 9 |
Vereinigtes Königreich | 6 |
Kanada | 6 |
Dänemark | 4 |
Sektoral
Health Technology | 25 |
Finance | 6 |
Commercial Services | 6 |
Consumer Services | 5 |
Distribution Services | 4 |
Operativ
Chairman | 25 |
Director/Board Member | 23 |
Corporate Officer/Principal | 16 |
Chief Executive Officer | 8 |
Independent Dir/Board Member | 7 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Thomas Werner | 25 |
Thomas O. Hecht | 24 |
Klaus Schollmeier | 17 |
Robert Phelps | 8 |
Uwe Fröhlich | 3 |
Richard Michael O'Brien | 1 |
Falk Nimmerjahn | 1 |
- Börse
- Insiders
- Sascha Tillmanns
- Unternehmensverbindungen